New Science on Display at PharmSci 360
Research in nanoparticles is exploding with innovations, driven by nanoparticles' role as delivery vehicles in the latest generation of vaccines.
At PharmSci 360, Oct. 22-25, in Orlando, FL, hear about new early development advances and uses of nanoparticles in new modality classes. Become familiar with new ingredients and manufacturing approaches to analytical, regulatory, and quality considerations.
Prologue
On Demand
Breaking Barriers for bRo5 Molecules: Formulation Strategies for Next-Generation Therapeutics
Ketan D. Patel, Ph.D., St. John's University
Symposium
Monday, October 23, 9:00 am-9:30 am
Advancing Nanoparticle-Based Delivery Systems with Novel Assessment Approaches
Xiaoming Xu, Ph.D., U.S. Food and Drug Administration
Monday, October 23, 9:30 am-10:00 am
NanoLipoSome Technology: a Toolbox for the Oral Delivery of Peptides
Ansgar Bögershausen, Losan Pharma
The Shift From Passive to Active Targeting Drug Delivery
Silvia Sonzini, Ph.D., AstraZeneca
Hot Topic
Monday, October 23, 2:30 pm-3:30 pm
Inhalable Aerosol Immune Engineering
Catherine A. Fromen, Ph.D., University of Delaware
Tuesday, October 24, 9:00 am-9:30 am
Advances in Regulated Bioanalytical Strategies Supporting Quantitation of Protein Degraders
Jim Shen, Ph.D., Bristol Myers Squibb
Wednesday, October 24, 10:00 am-10:30 am
High-Throughput Screening Workflow for Amorphous Solubility and Excipient Performance
Yuchen Fan, Genentech, Inc.
Speaker Spotlight
Wednesday, October 25, 10:00 am-11:00 am
Bioanalytical Strategies for Liponanoparticle-Dosed Therapeutics
Jason Pennucci, Moderna Therapeutics
Wednesday, October 25, 10:00 am-10:30 am
Real Time Imaging for Developing and Assessing Complex Pharmaceuticals
Xiuling Lu, Ph.D., University of Connecticut
Keynote
Wednesday, October 25, 1:30 pm-2:30 pm
State-of-The-Art Microfluidic Methodologies for Development of Micro- and Nanoparticles: Application to Drug Delivery Technologies
Helder Santos, University Medical Center Groningen
View the full program